Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3586
Gene Symbol: IL10
IL10
0.220 AlteredExpression disease BEFREE The infected and irradiated PUs exhibited a thinner neo-epidermis than those in the infected group, and the bacterial survival decreased in the laser group; the relative expression IL-1β mRNA levels demonstrated an increasing tendency while the relative expression IL-10 mRNA levels demonstrated a decreasing tendency in the infected + laser and laser groups. 31473868 2020
Entrez Id: 3586
Gene Symbol: IL10
IL10
0.220 Biomarker disease BEFREE TNFA, MMP9, and IL10 are possible therapeutic targets for pressure ulcer. 28188042 2017
Entrez Id: 3586
Gene Symbol: IL10
IL10
0.220 Biomarker disease RGD Analysis of Gene Expression in Experimental Pressure Ulcers in the Rat with Special Reference to Inflammatory Cytokines. 26177082 2015
Entrez Id: 2247
Gene Symbol: FGF2
FGF2
0.210 Biomarker disease BEFREE We then compared the effect of Derinat with that of salmon DNA and other PU therapeutic agents, prostaglandin E1 (PGE1) and basic fibroblast growth factor (bFGF), by using severe PU model mice. 30360946 2018
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.210 Biomarker disease RGD The angiogenic peptide vascular endothelial growth factor-basic fibroblast growth factor signaling is up-regulated in a rat pressure ulcer model. 23740668 2013
Entrez Id: 2247
Gene Symbol: FGF2
FGF2
0.210 Biomarker disease RGD The results showed that with an increase in the degree of pressure ulcers, the expression of VEGF and bFGF in pressure ulcers tissue are decreased. 23740668 2013
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.210 Biomarker disease BEFREE In the future, local administration and sustained, controlled release of VEGF(165) may decrease amputations in patients with diabetic foot ulcers and possibly accelerate closure of venous ulcers and pressure ulcers. 19282838 2009
Entrez Id: 3091
Gene Symbol: HIF1A
HIF1A
0.200 Biomarker disease RGD We detected increased expression and localization of HIF1-alpha in the deep muscle tissue of PU model rats, indicating that HIF1alpha is a key molecule in DTI and a valuable biomarker for hypoxia in DTI in the research field. 20223667 2010
Entrez Id: 213
Gene Symbol: ALB
ALB
0.060 AlteredExpression disease BEFREE In a conclusion, multiple ulcers, blood albumin level below 25 g/dl on admission and single caregiver were the three prognostic factors for recurrent pressure ulcer and the shortages of medical care out of hospital in northeast China need more attention urgently. 31405543 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.060 Biomarker disease BEFREE Pressure ulcer risk factors were peripheral vascular disease, end-stage disease, past pressure ulcer history, high risk group for pressure ulcer development, fever, haemoglobin, and albumin (all P < 0.05); only albumin (odds ratio: 0.210, P < 0.001) was significantly associated with pressure ulcer development as an independent risk factor. 30793859 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.060 Biomarker disease BEFREE Upper oral mucosa PU stage was related to commercial ETT holder use (r = 0.19, p = .044), haemoglobin(r = 0.24, p = .011), haematocrit (r = 0.27, p = .004), and serum albumin (r = -0.24, p = .012). 30551969 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.060 AlteredExpression disease BEFREE The age of the patient, the duration of the hospital stays, the presence of incontinence, albumin level problems, and a Braden score below 17 were found to be effective in the development of pressure ulcers. 29776817 2018
Entrez Id: 213
Gene Symbol: ALB
ALB
0.060 AlteredExpression disease BEFREE Whether laboratory values like serum albumin levels were the cause, the result or associated with pressure ulcer recurrence warrants further investigation. 29381242 2018
Entrez Id: 213
Gene Symbol: ALB
ALB
0.060 GeneticVariation disease BEFREE Despite orthogeriatric management, pressure ulcers were significantly associated with a low albumin level (RR 0.90, 95% CI 0.84-0.96; p = 0.003) and history of atrial fibrillation (RR 1.91, 95% CI 1.05-3.46; p = 0.033), coronary artery disease (RR 2.16, 95% CI 1.17-3.99; p = 0.014), and diabetes (RR 2.33, 95% CI 1.14-4.75; p = 0.02). 28852954 2017
Entrez Id: 3918
Gene Symbol: LAMC2
LAMC2
0.030 Biomarker disease BEFREE Decubitus CT Myelography for Detecting Subtle CSF Leaks in Spontaneous Intracranial Hypotension. 30819772 2019
Entrez Id: 80316
Gene Symbol: PPP1R2C
PPP1R2C
0.030 Biomarker disease BEFREE Incontinence-associated dermatitis is significantly associated with category I-IV sacral pressure ulcers. 31287188 2019
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.030 Biomarker disease BEFREE Decubitus CT Myelography for Detecting Subtle CSF Leaks in Spontaneous Intracranial Hypotension. 30819772 2019
Entrez Id: 3918
Gene Symbol: LAMC2
LAMC2
0.030 Biomarker disease BEFREE Digital subtraction myelography was then performed in patients positive for spinal longitudinal extradural CSF collection primarily in the prone position and in patients negative for spinal longitudinal extradural CSF collection in the lateral decubitus positions. 30923083 2019
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.030 Biomarker disease BEFREE Digital subtraction myelography was then performed in patients positive for spinal longitudinal extradural CSF collection primarily in the prone position and in patients negative for spinal longitudinal extradural CSF collection in the lateral decubitus positions. 30923083 2019
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.030 GeneticVariation disease BEFREE Fourteen postoperative complications in 10 patients (34%) included respiratory failure (14%), pneumonia (7%), urinary infection (10%), bed sores (10%), and CSF leak (7%). 28826916 2018
Entrez Id: 80316
Gene Symbol: PPP1R2C
PPP1R2C
0.030 Biomarker disease BEFREE The overall prevalence of pressure ulcers was calculated to be 12.7% (for stages I-IV), with the overall prevalence decreasing by 6.7% when the patients with stage-I were excluded. 29776817 2018
Entrez Id: 3918
Gene Symbol: LAMC2
LAMC2
0.030 GeneticVariation disease BEFREE Fourteen postoperative complications in 10 patients (34%) included respiratory failure (14%), pneumonia (7%), urinary infection (10%), bed sores (10%), and CSF leak (7%). 28826916 2018
Entrez Id: 80316
Gene Symbol: PPP1R2C
PPP1R2C
0.030 Biomarker disease BEFREE The overall prevalence of category I-IV pressure ulcers was 8·0% (95% CI 6·4-9·6), and the overall nosocomial pressure ulcer prevalence was 4·5% (95% CI 3·3-5·7). 27021798 2017
Entrez Id: 284697
Gene Symbol: BTBD8
BTBD8
0.020 Biomarker disease BEFREE Factors associated with reductions in functional status over 6 months were (a) institutionalized prior to hospitalization, (b) pressure sore before admission, (c) existing delirium, (d) impaired mobility at baseline, (e) increased APACHE II score upon ICU admission, and (f) use of mechanical ventilation during the ICU stay. 30022689 2020
Entrez Id: 7424
Gene Symbol: VEGFC
VEGFC
0.020 AlteredExpression disease BEFREE Interleukin-1α (IL-1α), vascular endothelial growth factor C (VEGF-C) and heat shock protein 90α (HSP90α) were expressed in the pressure ulcer model at a significantly different level compared to the blanchable erythema or intact skin during the time course. 31757582 2020